Extreme Medicine

ORIGINAL RESEARCH

Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2

Filin KN¹, Berzin IA², Bykov VN¹, Gladkikh VD¹, Loginova SYa³, Savenko SV³, Schukina VN³

¹ Federal State Unitary Enterprise Research & Production Center "Pharmaceutical Protection" of Federal Medical Biological Agency, Khimki, Russia

² Federal Medical and Biological Agency, Moscow, Russia

³ Federal State Budgetary Institution "48 Central Research Institute" of the Ministry of Defense of the Russian Federation, Sergiev Posad-6, Russia

About paper

Received: 2020-06-25 Accepted: 2020-07-17 Published online: 2020-08-09

Table 1.

Table 2.

Table 3.

Link to the next paper will be sent to the indicated e-mail's:

ORIGINAL RESEARCH Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2

Filin KN, Berzin IA, Bykov VN, Gladkikh VD, Loginova SYa, Savenko SV, Schukina VN

Published in "Bulletin of RSMU" 3, 2020

I want to receive a copy of this message

Vancouver style

Filin KN, Berzin IA, Bykov VN, Gladkikh VD, Loginova SY, Savenko SV, et al. Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2. Extreme Medicine. 2020; (3): 12–6. DOI: 10.47183/mes.2020.006

Harvard style

Filin, K. N., Berzin, I. A., Bykov, V. N., Gladkikh, V. D., Loginova, S. Y., Savenko, S. V., et al. (2020), "Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2", Extreme Medicine, no. 3, p. 12–16. DOI: 10.47183/mes.2020.006

Remember me

Forgot password?

I accept Editorial Policies of the journal

Archive

2020 / 03

ORIGINAL RESEARCH

Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2